Oncoclinicas Holder Joins Push to Require Buyout by Top Investor

A major investor in Oncoclinicas do Brasil Servicos Medicos SA is throwing its weight behind a movement to require the company’s biggest shareholder to make a tender offer for the rest of the stock.

Latache Gestao de Recursos, a fund that focuses on distressed assets, argues that top investor Centaurus Brazil Holdings LLC triggered a poison pill provision when its stake surpassed 15% in a complex shareholder restructuring. Latache’s position is that once Centaurus passed that threshold, it was required to make an offer for the other shares.